BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35572350)

  • 1. Very late stent thrombosis lacking findings of the typical causes on optical coherence tomography in a patient with SARS-CoV-2.
    Shinkai W; Hashikata T; Kameda R; Sato N; Minami Y; Ako J
    J Cardiol Cases; 2022 Sep; 26(3):197-199. PubMed ID: 35572350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence Tomography.
    Taniwaki M; Radu MD; Zaugg S; Amabile N; Garcia-Garcia HM; Yamaji K; Jørgensen E; Kelbæk H; Pilgrim T; Caussin C; Zanchin T; Veugeois A; Abildgaard U; Jüni P; Cook S; Koskinas KC; Windecker S; Räber L
    Circulation; 2016 Feb; 133(7):650-60. PubMed ID: 26762519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure Mechanisms and Neoatherosclerosis Patterns in Very Late Drug-Eluting and Bare-Metal Stent Thrombosis.
    Nakamura D; Attizzani GF; Toma C; Sheth T; Wang W; Soud M; Aoun R; Tummala R; Leygerman M; Fares A; Mehanna E; Nishino S; Fung A; Costa MA; Bezerra HG
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Earlier Versus Delayed Presentation of Very Late Drug-Eluting Stent Thrombosis: An Optical Coherence Tomographic Study.
    Lee SY; Ahn JM; Mintz GS; Hur SH; Choi SY; Kim SW; Cho JM; Hong SJ; Kim JW; Hong YJ; Lee SG; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Park SJ; Hong MK
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes of very late stent thrombosis investigated using optical coherence tomography.
    Amioka M; Shiode N; Kawase T; Kagawa Y; Yamane K; Takahashi L; Okubo Y; Tamekiyo H; Otsuka M; Okimoto T; Masaoka Y; Hayashi Y; Itakura K; Kato M; Dote K; Kihara Y;
    Intern Med; 2014; 53(18):2031-9. PubMed ID: 25224184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo optical coherence tomography of very late drug-eluting stent thrombosis compared with late in-stent restenosis.
    Miyazaki S; Hiasa Y; Takahashi T; Yano Y; Minami T; Murakami N; Mizobe M; Tobetto Y; Nakagawa T; Chen PM; Ogura R; Miyajima H; Yuba K; Hosokawa S; Kishi K; Ohtani R
    Circ J; 2012; 76(2):390-8. PubMed ID: 22130319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical Coherence Tomography Findings in Patients With Coronary Stent Thrombosis: A Report of the PRESTIGE Consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort).
    Adriaenssens T; Joner M; Godschalk TC; Malik N; Alfonso F; Xhepa E; De Cock D; Komukai K; Tada T; Cuesta J; Sirbu V; Feldman LJ; Neumann FJ; Goodall AH; Heestermans T; Buysschaert I; Hlinomaz O; Belmans A; Desmet W; Ten Berg JM; Gershlick AH; Massberg S; Kastrati A; Guagliumi G; Byrne RA;
    Circulation; 2017 Sep; 136(11):1007-1021. PubMed ID: 28720725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A unique case of ST-elevation myocardial infarction related to very late stent thrombosis.
    Takahashi T; Okayama H; Hiasa G; Kazatani Y
    J Cardiol Cases; 2018 Feb; 17(2):63-67. PubMed ID: 30279857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical coherence tomography findings of very late stent thrombosis after drug-eluting stent implantation.
    Ko YG; Kim DM; Cho JM; Choi SY; Yoon JH; Kim JS; Kim BK; Choi D; Jang Y; Hong MK
    Int J Cardiovasc Imaging; 2012 Apr; 28(4):715-23. PubMed ID: 21656060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherence tomography analysis of the stent strut and prediction of resolved strut malapposition at 3 months after 2nd-generation drug-eluting stent implantation.
    Izumi D; Miyahara M; Fujimoto N; Fukuoka S; Sakai M; Dohi K; Ito M
    Heart Vessels; 2016 Aug; 31(8):1247-56. PubMed ID: 26334709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoatherosclerosis in Patients With Coronary Stent Thrombosis: Findings From Optical Coherence Tomography Imaging (A Report of the PRESTIGE Consortium).
    Joner M; Koppara T; Byrne RA; Castellanos MI; Lewerich J; Novotny J; Guagliumi G; Xhepa E; Adriaenssens T; Godschalk TC; Malik N; Alfonso F; Tada T; Neumann FJ; Desmet W; Ten Berg JM; Gershlick AH; Feldman LJ; Massberg S; Kastrati A;
    JACC Cardiovasc Interv; 2018 Jul; 11(14):1340-1350. PubMed ID: 30025727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry.
    Souteyrand G; Amabile N; Mangin L; Chabin X; Meneveau N; Cayla G; Vanzetto G; Barnay P; Trouillet C; Rioufol G; Rangé G; Teiger E; Delaunay R; Dubreuil O; Lhermusier T; Mulliez A; Levesque S; Belle L; Caussin C; Motreff P;
    Eur Heart J; 2016 Apr; 37(15):1208-16. PubMed ID: 26757787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neo-atherosclerosis in very late stent thrombosis of drug eluting stent.
    Al Mamary A; Dariol G; Napodano M
    J Saudi Heart Assoc; 2014 Oct; 26(4):226-30. PubMed ID: 25278726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very late stent thrombosis after paclitaxel-eluting stent implantation with full neointimal tissue coverage visualized by optical coherence tomography.
    Ishikawa Y; Itoh T; Fusazaki T; Komuro K; Nakajima S; Nakamura M; Morino Y
    J Cardiol Cases; 2013 Jun; 7(6):e168-e170. PubMed ID: 30533154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of very late stent thrombosis on the protruded struts at the left main coronary bifurcation.
    Murasato Y; Shibao K; Meno K; Takenaka K
    J Cardiol Cases; 2020 Jul; 22(1):40-43. PubMed ID: 32636969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical coherence tomography evaluation of late strut coverage patterns between first-generation drug-eluting stents and everolimus-eluting stent.
    Toledano Delgado FJ; Alvarez-Ossorio MP; de Lezo Cruz-Conde JS; Bellido FM; Romero Moreno MÁ; Fernández-Aceytuno AM; de Lezo Herrerosde Tejada JS; Pineda SO; Saint-Gerons JM; Pavlovic D
    Catheter Cardiovasc Interv; 2014 Nov; 84(5):720-6. PubMed ID: 24174291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Strut Coverage in Patients Receiving Drug-Eluting Stents and its Implications for Dual Antiplatelet Therapy: A Randomized Trial.
    Lee SY; Kim JS; Yoon HJ; Hur SH; Lee SG; Kim JW; Hong YJ; Kim KS; Choi SY; Shin DH; Nam CM; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    JACC Cardiovasc Imaging; 2018 Dec; 11(12):1810-1819. PubMed ID: 29454763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very early tissue coverage after drug-eluting stent implantation: an optical coherence tomography study.
    Takahara M; Kitahara H; Nishi T; Miura K; Miyayama T; Sugimoto K; Nakayama T; Fujimoto Y; Kobayashi Y
    Int J Cardiovasc Imaging; 2017 Jan; 33(1):25-30. PubMed ID: 27601229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.